Bosch John Roderick Ten Sells 1,416 Shares of Billiontoone (NASDAQ:BLLN) Stock

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $97.54, for a total value of $138,116.64. Following the transaction, the senior vice president directly owned 25,051 shares in the company, valued at approximately $2,443,474.54. This trade represents a 5.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $100.00, for a total transaction of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total transaction of $131,582.62.
• On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total transaction of $169,920.00.
• On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The shares were sold at an average price of $101.47, for a total transaction of $287,363.04.

Billiontoone Stock Up 0.3%

Shares of NASDAQ:BLLN opened at $98.77 on Friday. Billiontoone, Inc. has a 1-year low of $61.96 and a 1-year high of $150.44. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. The stock has a market cap of $4.66 billion and a P/E ratio of 141.10. The firm has a fifty day moving average price of $111.64 and a 200 day moving average price of $95.81.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, meeting analysts’ consensus estimates of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The company had revenue of $109.45 million for the quarter. Sell-side analysts predict that Billiontoone, Inc. will post 0.83 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in BLLN. MCF Advisors LLC lifted its position in Billiontoone by 330.8% in the second quarter. MCF Advisors LLC now owns 448 shares of the company’s stock valued at $54,000 after purchasing an additional 344 shares during the period. Integrated Wealth Concepts LLC acquired a new position in Billiontoone during the 2nd quarter worth approximately $29,000. Thrive Wealth Management LLC purchased a new position in shares of Billiontoone during the 2nd quarter worth approximately $240,000. Jasper Ridge Partners L.P. acquired a new stake in shares of Billiontoone in the 2nd quarter valued at approximately $615,000. Finally, Wasatch Advisors LP lifted its holdings in shares of Billiontoone by 40.2% in the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock valued at $62,160,000 after buying an additional 148,446 shares during the period.

Wall Street Analyst Weigh In

BLLN has been the topic of several recent research reports. Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. BTIG Research lowered their target price on Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, August 6th. JPMorgan Chase & Co. lowered their target price on Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research note on Thursday, August 6th. Guggenheim started coverage on Billiontoone in a report on Monday, June 29th. They issued a “buy” rating and a $125.00 target price on the stock. Finally, Canaccord Genuity Group started coverage on Billiontoone in a research note on Wednesday, September 2nd. They set a “buy” rating and a $120.00 price target for the company. Seven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $125.88.

Billiontoone Company Profile

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.